Smart vest for heart patients: could it cut hospital readmissions?

NCT ID NCT07622472

Not yet recruiting Disease control Sponsor: Zoll Medical Corporation Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a wearable device that tracks heart rate, breathing, activity, and fluid buildup in people recently hospitalized for heart failure. 800 participants will either get standard care or standard care plus the device for 90 days. The goal is to see if early alerts from the device help doctors prevent serious events like death or rehospitalization.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Wearable monitoring device (Heart Failure Management System)
What this could lead to: If successful, this device could help doctors detect worsening heart failure early and reduce hospital visits and deaths.
What could go wrong: The trial hasn't started yet, and it's unclear if the device will meaningfully improve outcomes over standard care. Device data may lead to false alarms or missed warnings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

heart failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEART FAILURE

Contacts and locations

Locations

CHU Nancy

Nancy, Grand Est, 54000, France
Hospital Universitario 12 de Octubre

Madrid, Spain
Justus-Liebig University Giessen

Giessen, 35390, Germany
PIM MSWiA Hospital

Warsaw, Poland
Policlinico Casilino

Roma, Italy
Southampton University Hospital NHS Foundation Trust

Southampton, United Kingdom
UMC Utrecht

Utrecht, Netherlands
University Zurich

Zurich, Switzerland
Uppsala University Hospital

Uppsala, Sweden

More trials for these conditions

Other studies related to the condition(s) this trial covers.